Latka logo
Mammoth Biosciences logo

Mammoth Biosciencesrevenue, valuation & funding

Brisbane, CaliforniaFounded 2017CEO Trevor Martin

Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop potential long-term curative therapies and decentralized precision diagnostics.

mammoth.bioLinkedInUpdated Nov 24, 2025
Annual revenue
$40M
Dec 2022
Valuation
$1B
Sep 2021
Total raised
$332.5M
3 rounds
Employees
168
Nov 2025

Mammoth Biosciences revenue

Mammoth Biosciences' annual revenue was $40M in December 2022 (source not recorded), the most recent figure on record.

$0
$10M
$20M
$30M
$40M
$0
–
$40M
20172018–212022
ReportedFounded 2017 at $0; every reading has its own bar
As ofRevenueSource
Dec 2022$40M–

– source not recorded

Mammoth Biosciences valuation

Mammoth Biosciences is privately held, so there is no Mammoth Biosciences stock to buy. Investors valued it at $1B in its September 2021 Series D.

Mammoth Biosciences funding rounds & investors

Mammoth Biosciences has raised $332.5M across three rounds since 2018. The latest was a $264.5M Series D in September 2021.

DateRoundRaisedValuationSource
Sep 2021Series D$264.5M$1BBusiness Wire
Jan 2020Series C$45M–Forbes
Jul 2018Series A$23M–TechCrunch
Total raised$332.5M

Mammoth Biosciences CEO, founders & employees

Trevor Martin founded Mammoth Biosciences in 2017 and runs it as CEO. Mammoth Biosciences has 168 employees (November 2025, LinkedIn).

0
50
100
150
168
2025
ReportedOne figure per year; a reported figure wins over an estimate

Mammoth Biosciences FAQ

What is Mammoth Biosciences' revenue?

Mammoth Biosciences' annual revenue was $40M in December 2022 (source not recorded). No later figure is on record.

What is Mammoth Biosciences' valuation?

Investors valued Mammoth Biosciences at $1B in its September 2021 Series D, according to Business Wire.

How much funding has Mammoth Biosciences raised?

Mammoth Biosciences has raised $332.5M across three funding rounds. The latest was a $264.5M Series D in September 2021.

Is Mammoth Biosciences publicly traded?

No. Mammoth Biosciences is a private company, so its shares aren't traded on a stock exchange.

How many employees does Mammoth Biosciences have?

Mammoth Biosciences has 168 employees as of November 2025, according to LinkedIn.

Who is the CEO of Mammoth Biosciences?

Trevor Martin is the CEO of Mammoth Biosciences and founded the company in 2017.

Who founded Mammoth Biosciences?

Trevor Martin founded Mammoth Biosciences in 2017.

How this page is sourced

4 from public sources. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Nov 24, 2025Data disclaimerReport a correctionClaim this profileRun Mammoth Biosciences? Join the podcast